-+ 0.00%
-+ 0.00%
-+ 0.00%

MILESTONE PHARMACEUTICALS ENROLLS FIRST CANADIAN STUDY PARTICIPANT IN REVERA-301 PHASE 3 PIVOTAL TRIAL EVALUATING ETRIPAMIL NASAL SPRAY FOR AFIB-RVR

Reuters·09/24/2026 12:02:19